Kevin H.

Kevin H. has extensive experience in the field of healthcare and pharmaceuticals. Kevin began their career at the University of Tennessee in 1991, where they served as an Associate Professor of Medical Oncology and Director of Developmental Therapeutics. In 1999, they joined Veterinary Cancer Associates, P.A. as the Chief of Medical Oncology Services and Research Director.

In 2007, Kevin H. became the Chief Medical Officer for Hill's Pet Nutrition, Inc. in Topeka, Kansas. During their time there, they managed medical operations and directed research efforts.

Currently, Kevin H. is the Chief Scientific Officer and Executive Vice President at Tri-Source Pharma Holdings. In this role, they are dedicated to providing and maintaining hard-to-find specialty pharmaceuticals for human and animal healthcare providers.

Throughout their career, Kevin H. has demonstrated a strong commitment to advancing medical oncology and developing innovative therapies.

Kevin H. has a strong education background in the field of veterinary medicine. Kevin obtained a Bachelor of Science (B.S.) degree in Animal Sciences from Purdue University in 1983. Following this, they pursued a Doctor of Veterinary Medicine (D.V.M.) degree at the same institution, which they completed in 1987. Kevin then continued their education at Purdue University and earned a Doctor of Philosophy (PhD) degree in Cytogenetics, which they completed in 1992.

In terms of additional certifications, Kevin has a certification in Veterinary Medical Oncology from the American College of Veterinary Internal Medicine. However, specific details such as the month and year of obtaining this certification are not provided.